Get the Stockscreener App
0.80
2.44%
-0.02
After Hours:
.82
0.02
+2.50%
Dariohealth Corp stock is traded at $0.80, with a volume of 43,183.
It is down -2.44% in the last 24 hours and up +20.54% over the past month.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
See More
Previous Close:
$0.82
Open:
$0.82
24h Volume:
43,183
Relative Volume:
0.11
Market Cap:
$30.34M
Revenue:
$20.35M
Net Income/Loss:
$-59.43M
P/E Ratio:
-0.7767
EPS:
-1.03
Net Cash Flow:
$-30.96M
1W Performance:
+6.67%
1M Performance:
+20.54%
6M Performance:
-17.53%
1Y Performance:
-45.58%
1-Day Range:
$0.7804
$0.82
1-Week Range:
$0.71
$0.825
52-Week Range:
$0.5011
$1.9298
Dariohealth Corp Stock (DRIO) Company Profile
Name
Dariohealth Corp
Sector
Industry
Phone
972-4-770-6377
Address
322 W 57TH ST. #33B, NEW YORK
Compare DRIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DRIO
Dariohealth Corp
|
0.80 | 30.34M | 20.35M | -59.43M | -30.96M | -1.03 |
|
VEEV
Veeva Systems Inc
|
227.54 | 34.18B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
56.65 | 9.62B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
52.90 | 7.09B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
85.87 | 6.94B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.02 | 6.06B | 906.14M | -52.62M | 89.62M | -0.3621 |
Dariohealth Corp Stock (DRIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-29-25 | Downgrade | TD Cowen | Buy → Hold |
| May-13-22 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Apr-22-21 | Initiated | Cowen | Outperform |
| Mar-23-21 | Initiated | Stifel | Buy |
| Feb-25-21 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-01-21 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Aug-17-20 | Initiated | Aegis Capital | Buy |
| Aug-29-17 | Initiated | Aegis Capital | Buy |
| May-09-16 | Initiated | Rodman & Renshaw | Buy |
View All
Dariohealth Corp Stock (DRIO) Latest News
DarioHealth says CFO Zvi Ben-David to retire, appoints Chen Franco-Yehuda as successor - MSN
DarioHealth announces executive changes and new CFO appointment - Investing.com Australia
DarioHealth announces executive changes and new CFO appointment By Investing.com - Investing.com Nigeria
DarioHealth Announces CFO Resignation and Successor - TipRanks
DarioHealth appoints new CFO as Ben-David retires By Investing.com - Investing.com South Africa
DarioHealth (DRIO) Appoints New CFO as Zvi Ben-David Retires - GuruFocus
DarioHealth Corp. Announces CFO Transition, Effective May 15, 2025 - marketscreener.com
DarioHealth Appoints Chen Franco-Yehuda as CFO - citybiz
DarioHealth appoints new CFO as Ben-David retires - Investing.com
DarioHealth (DRIO) Welcomes New CFO as Zvi Ben-David Announces R - GuruFocus
DarioHealth Announces CFO Transition - marketscreener.com
DarioHealth partners with benefits administrator to expand employer services By Investing.com - Investing.com Canada
Dariohealth Collaborates With Leading National Benefit Plan Administrator To Offer Cardiometabolic Solution - marketscreener.com
DarioHealth partners with benefits administrator to expand employer services - Investing.com Australia
DarioHealth Targets $100B GLP-1 Market with New National Benefits Partnership - Stock Titan
DarioHealth Collaborates with Leading National Benefit Plan Administrator to Offer Cardiometabolic Solution including a GLP-1 Support Program to Employers (PR Newswire) - Aktiellt
DarioHealth Corp. (NASDAQ:DRIO) Screens Well But There Might Be A Catch - simplywall.st
Indo-Asian News Service - Indo-Asian News Service (IANS)
Top U.S. Healthcare Institution Deploys DarioHealth's Full Suite, Contributing to 2025 Revenue Growth and Market Expansion - Nasdaq
Leading US Medical Center Chooses DarioHealth's AI Platform for Multi-Condition Care - Stock Titan
DarioHealth (NASDAQ:DRIO) Stock Price Passes Below 200 Day Moving Average – Should You Sell? - Defense World
Head to Head Survey: DarioHealth (NASDAQ:DRIO) & Sonoma Pharmaceuticals (NASDAQ:SNOA) - Defense World
DarioHealth stock hits 52-week low at $0.56 amid market challenges - Investing.com Canada
DarioHealth stock hits 52-week low at $0.56 amid market challenges By Investing.com - Investing.com South Africa
Investor Network Invites You to the DarioHealth Fourth Quarter and Full Year 2016 Earnings Conference Call and Webcast Live on Thursday, March 23, 2017 - ACCESS Newswire
DarioHealth (NASDAQ:DRIO) Stock Passes Below 200-Day Moving Average – Here’s Why - Defense World
DarioHealth (DRIO) Upgraded to Strong Buy: Here's What You Should Know - MSN
Market Alert: Hinge Health's Multi-Billion Dollar Expected IPO Highlights 600% Valuation Opportunity for DarioHealth - Sharewise
C O R R E C T I O N -- DarioHealth Corp./ -February 06, 2025 at 08:30 am EST - Marketscreener.com
DarioHealth granted extension to regain Nasdaq compliance By Investing.com - Investing.com South Africa
DarioHealth (DRIO) to Release Earnings on Thursday - Defense World
DarioHealth granted extension to regain Nasdaq compliance - Investing.com
DarioHealth (NASDAQ:DRIO) Stock Price Crosses Below 200 Day Moving Average – Here’s Why - Defense World
DarioHealth Reports Strong Revenue Growth in 2024 - TipRanks
DarioHealth Announces New Agreement with a Large Regional Health Plan - Longview News-Journal
/C O R R E C T I O N -- DarioHealth Corp./ - Yahoo Finance
DarioHealth Appoints New Auditing Firm PwC Member - TipRanks
DarioHealth (NASDAQ:DRIO) Price Target Lowered to $2.00 at Stifel Nicolaus - Defense World
DarioHealth’s Earnings Call Highlights Robust Growth - TipRanks
Stifel cuts DarioHealth stock target to $2, maintains buy rating - Investing.com
Stifel cuts DarioHealth stock target to $2, maintains buy rating By Investing.com - Investing.com South Africa
DarioHealth Corp. (NASDAQ:DRIO) Q4 2024 Earnings Call Transcript - Insider Monkey
Dariohealth Corp Stock (DRIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.53%
1.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):